Coronary Microvascular Disease clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for

  • FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial

    Sorry, accepting new patients by invitation only

    This study seeks to evaluate if the diagnostic performance of 18F-flurpiridaz positron emission tomography (PET) myocardial perfusion imaging (MPI), given the radiotracer's properties, is non-inferior to the currently most widely utilized PET MPI radiopharmaceutical, 82Rb-chloride.

    at UCLA

  • Serial PET MPI in Patients Undergoing Cancer Treatment

    Sorry, accepting new patients by invitation only

    This study aims to evaluate the effects of cardiotoxic cancer therapies on myocardial blood flow (MBF) and perfusion in a prospective sample of VA patients.

    at UCLA

Our lead scientists for Coronary Microvascular Disease research studies include .

Last updated: